The Valley Desk

NCT02652780 · Interventional trial

Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)

Overall registry status Completed

Phase 3

Conditions Optic, Atrophy, Hereditary, Leber

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov